LivaNova participated in a series A round for Shiratronics that will fund the progression of its migraine headache treatment device toward clinical testing.
Shiratronics, a US-based startup developing a migraine headache-treatment system, has closed a $33m series A round that included medical device producer LivaNova.
Venture capital firms US Venture Partners (USVP) and Strategic HealthCare Investment Partners (SHIP) co-led the round with Amzak Health, a vehicle for asset manager Amzak Capital Management, while Aperture Venture Partners and an unnamed academic institution also took part.
Spun off from medical device accelerator NuXcel earlier this year, Shiratronics is working on a device that will treat…
